Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
22 hedge funds and large institutions have $1.03M invested in Intellipharmaceuticals International Inc. in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
341% more call options, than puts
Call options by funds: $216K | Put options by funds: $49K
79% more capital invested
Capital invested by funds: $578K → $1.03M (+$454K)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
22% more funds holding
Funds holding: 18 → 22 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFA
First Foundation Advisors
Irvine,
California
|
+$181K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$75.4K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$33.8K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$17.9K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$17.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$81.6K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$35.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$22K |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$3.95K |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$90 |
IPCI Hedge Fund Activity: Q3 2016 in Review
22 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q3 2016, worth a combined $1.03M — up 79% from $578K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new IPCI positions and 1 closed out — a net gain of 4 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was First Foundation Advisors, opening a new position worth an estimated $181K. The largest seller was Royal Bank of Canada, cutting an estimated $81.6K.
- 22 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q3 2016, up from 18 in Q2 2016.
- Funds reported $1.03M of Intellipharmaceuticals International Inc. stock for Q3 2016, up 79% quarter-over-quarter.
- 5 funds opened new Intellipharmaceuticals International Inc. positions in Q3 2016 and 1 closed out, a net change of +4 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q3 2016 was First Foundation Advisors, an estimated $181K added.
- The largest Intellipharmaceuticals International Inc. seller in Q3 2016 was Royal Bank of Canada, an estimated $81.6K sold.
Based on aggregated 13F filings for Q3 2016.